Medications
GLP-1s, oral weight loss medications
Monthly Cost
$149-$399
Speed to Start
Moderate
Est. 2020
About Allara Health
Allara Health was founded in 2020 to address a population that mainstream medicine has chronically underserved: women with PCOS (polycystic ovary syndrome) and hormonal conditions that make weight management exceptionally difficult. The platform offers both brand-name and compounded GLP-1 medications alongside oral weight-loss medications, with pricing ranging from $149-$399 per month depending on the treatment plan.
Allara’s clinical model is built around a multidisciplinary care team that includes OBGYNs and registered dietitians working in coordination. This is not a platform where a single provider writes a prescription and disappears. Patients receive lab testing to identify hormonal imbalances, insulin resistance markers, and other PCOS-related factors that directly influence which GLP-1 medication and dosage will be most effective. The dietitian component adds nutritional counseling tailored to PCOS, which has specific dietary considerations around insulin and androgen management.
Third-party reviews strongly support Allara’s clinical approach. The platform holds a 4.4-star rating across 725+ reviews on Trustpilot, with patients frequently praising the depth of their initial consultations and the sense of finally being heard by providers who understand hormonal weight gain. The company carries an F rating with the Better Business Bureau, which our team flags as a concern, though the Trustpilot volume and sentiment provide a meaningful counterweight.
Like Midi Health, Allara accepts insurance, which can substantially reduce costs for patients with qualifying coverage. The platform’s ability to prescribe both brand-name GLP-1s and compounded alternatives, plus oral weight-loss options, gives clinicians maximum flexibility to tailor treatment. For PCOS patients who have tried and failed on generic weight-loss programs, this hormone-informed, multi-medication approach represents a fundamentally different and more clinically appropriate pathway.
Our editorial team ranks Allara Health among the top GLP-1 telehealth platforms we have evaluated. The PCOS and hormonal specialization fills a critical gap, the care team model with OBGYNs and dietitians sets a high standard for clinical thoroughness, and the insurance acceptance makes it financially accessible. The F BBB rating is the primary counterweight, and we encourage Allara to address the underlying complaints to match their clinical excellence with stronger third-party institutional trust.
Allara Health GLP-1 Medications
At a Glance
Medications Offered
GLP-1s, oral weight loss medications
Both
Cost & Insurance
- Monthly: $149-$399
- 6-month estimate: $894-$2,394
- Insurance: Yes
- Self-pay: Yes
Clinical Features
- Lab testing: Yes
- Dietitian access: Yes
- Verified Pharmacy: Not disclosed; primarily brand-name focus
- BBB Rating: F
Delivery & Access
- Format: Both (Oral and Subcutaneous)
- Nationwide telehealth: Yes
- Speed: Moderate
- Spanish-speaking providers: Not available
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.
What the Allara Health Intake Looks Like
We walked through Allara Health’s full onboarding ourselves, from the landing page through to program selection and checkout. Here’s what an actual prospective patient encounters before enrolling.
/ 10
The pre-enrollment flow is essentially a marketing qualification funnel, not a clinical intake. Full clinical assessment — labs, hormone panels, provider evaluation — happens after enrollment during your first appointments. No FDA screens, no comorbidities, no medication list.
/ 10
Among the lowest friction flows we’ve evaluated. 18 screens in ~4 minutes, account creation deferred to screen 15, three social proof interstitials embedded to keep momentum. Insurance-first path minimizes upfront cost anxiety.
The 6 Stages
What Allara’s Pre-Enrollment Flow Does Collect
Allara does not perform any clinical safety screening before enrollment. There are no FDA contraindication checks (MTC, MEN2), no comorbidity questions, no medication or allergy list, no mental health screening, no eating disorder screen, no family history, and no substance use questions. This is by design — Allara’s model defers all clinical assessment to post-enrollment provider visits and lab testing, where OBGYNs and registered dietitians conduct a thorough evaluation. The pre-enrollment flow is optimized for conversion, not clinical gatekeeping.
Allara is the only platform in our evaluation that hard-disqualifies patients based on biological sex. If you select Male or Intersex on the sex-at-birth screen, you immediately see: “Unfortunately, you’re not eligible for our care program at this time. Based on your gender at birth, you are not medically eligible for our program at this time.” The platform’s clinical model is built around PCOS, hormonal imbalances, insulin resistance, and female-specific metabolic conditions, which is why this gate exists. For women who have struggled with these conditions and been dismissed by general providers, Allara’s specialization is a meaningful differentiator — but it is strictly not for men.
Source: GLP-1.Reviews editorial walkthrough on April 22, 2026. We completed every screen of the Allara Health onboarding using a representative female candidate persona and stopped before submitting any payment information.
Opens allarahealth.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.
